In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan

Liu, Chia-YingChia-YingLiuYU-TSUNG HUANGLiao, Chun-HsingChun-HsingLiaoPO-REN HSUEH2019-07-242019-07-242008-070066-4804https://www.scopus.com/record/display.uri?eid=2-s2.0-46249122640&origin=inward&txGid=da2c3b8a910fedabb6b651d4de839be8#https://scholars.lib.ntu.edu.tw/handle/123456789/415244All 198 Salmonella isolates (58.6% of isolates were resistant to tetracycline), 92 Vibrio isolates (4.4% of isolates were resistant to tetracycline), and 200 of 201 Aeromonas isolates (39.3% of isolates were resistant to tetracycline; 1 A. caviae isolate had a tigecycline MIC of 4 mug/ml) in our study were susceptible to tigecycline, by U. S. Food and Drug Administration criteria for Enterobacteriaceae.enIn vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwanjournal article10.1128/AAC.00002-08184745852-s2.0-46249122640WOS:000257183400057https://api.elsevier.com/content/abstract/scopus_id/46249122640